% | $
Quotes you view appear here for quick access.

Cytokinetics, Incorporated Message Board

  • dctrig dctrig Feb 25, 2013 5:28 PM Flag

    Cytokinetics Has The Best of Both Worlds

    1) Amgen undoubtedly studied very hard the trial results in Mecarbil before choosing the oral formulations. Very few small biotechs have the backing of such a premier biotech; in fact, if you peruse Amgen's website you'll see that Amgen does not enter many partnerships with small biotechs: they choose the cream of the crop.

    2) Cytokinetics is running the ALS trial, but the bar is so low that there is probably a 50-60% likelihood of at least a subset that is helped. Vocal ALS groups are a fantastic partner to have.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
6.35-0.17(-2.61%)Jul 2 4:00 PMEDT